🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#LSU Baseball recruiting class 👀👀

Will close down candidates to interview over next month so feel free to reach out if interested in fellowship. Pgy4s only.

Gemcitabine + cisplatin + anti-PD-1 led to complete response in 43% of patients with muscle-invasive #BladderCancer, which facilitated bladder sparing and was associated with long-term bladder-intact survival. Matt Galsky The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai nature.com/articles/s4159…

Happy Halloween from Angel and Joe! #GeauxTigers

Our collaborative review on LND in GU cancers; tremendous effort by Amanda Myers MD Anderson Cancer Center #OncSurgery European Urology Oncology Open Access link: authors.elsevier.com/a/1i6Q09Cfv-xp… Alberto Briganti B.C. Leibovich MD #SethLerner Marco Moschini Morgan Roupret Shahrokh F. Shariat Philippe spiess @Astenzl

Very important data to inform mgmt timeline for pts. Historically, unknown growth rate pushed for urgent surgery. This shows avg growth rate of RCC venous tumor thrombus is ~1 cm per month. Use info accordingly. Thx to all authors but esp to Nimrod Barashi, M.D. and Ippolito Lab

Results from PREVENT trial. No difference in complications for TP vs TR prostate biopsy, although NO antibiotics used in TP vs targeted ABX in TR. ABX stewardship is important! So proud to be part of this excellent group, there is more to come!!

Explaining to Homeland Security why I was yelling “OPEN SHOOTER” in the middle of an airport <<<<<<

Remember how unnecessarily expensive medical school was? When we had to buy all of that medical school equipment including otoscopes, ophalmoscopes, neurology stuff. We had to buy this with loan money. The only thing we needed was a stethacope.

Online now: Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer dlvr.it/T2NZ6V

The final results of #POUT adjuvant trial in Upper Tract Urothelial cancer (UTUC) adjuvant trial are now published in Journal of Clinical Oncology. This is a landmark study in the field and 💙alison birtle + team should be celebrated. 5-year DFS (1EP): 62% vs. 45%, HR 0.55 (95% CI, 0.38-0.80,

Fantastic talk and insights about cutting edge changes in prostate cancer, biopsy technique, and focal therapy from my friend and legend Amir Lebastchi, MD !! Learned a lot. Fun to have you at Rutgers Cancer Institute Rutgers RWJ Urology Saum Ghodoussipour Thomas Jang YUO

Very pleased to announce TARGET, our new publication in European Urology! ✨ Available open access: sciencedirect.com/science/articl… 🏆 TARGET will also be presented at #EAU24 and I am delighted to announce it has also been awarded Best Abstract by a Resident at #EAU24! 🏆 A brief 🧵 1/14

This is the updated #Algorithm for #BladderCancer. Nivo/Gem/Cis was not approved at the time of this discussion w/ Karine Tawagi MD and Sia Daneshmand, M.D. but has been incorporated in this is mage below. #OncTwitter #MedTwtitter #gusm #MedEd CancerNetwork® #OncEd

1-yr uro onc fellowship. Seeking current pgy-4. Dm > 100 cystectomies, 200 plus robotic cases. 30-40 complex retroperitoneal cases. In 3rd year of program. Fellow and residencies 1- uchicago 2 residency- Utah 3- Mississippi 4-incoming Utah YUO Southeastern Section Amer. Urol. Assn.

1-yr uro onc fellowship. Seeking pgy-4. Salary 90 k plus moving expenses. Interview in person or SUO > 100 rc, 200 plus robot. 30-40 rp cases. In 3rd year of program. Dm Fellow and residencies 1- uchicago 2 residency- Utah 3- U miss 4- Utah Western Section AUA Southeastern Section Northeastern Section YUO

Prisma Health Fellowship in Urologic Oncology fellow Nick Noble giving an update on high impact bladder cancer articles of 2024. Society of Urologic Oncology Ryan Werntz

Just in time for AUA - A high-quality succinct review on contemporary intravesical therapy on NMIBC by the great Saum Ghodoussipour & all ⭐️ colleagues in European Urology Beautiful figures too! A valuable resource for patients & urologists Bladder Cancer Advocacy Network YUO pubmed.ncbi.nlm.nih.gov/40253283/

Excited to share this paper which has been many years in the making! This is the first publication of a predictive (AI-histology based) biomarker to guide rational use of BCG vs Gem/Doce for newly diagnosed HG NMIBC pubmed.ncbi.nlm.nih.gov/40287344/ Curves say it all 👇🏾

After an awesome conversation with Barry Odom I’m blessed to receive an offer from Purdue Football. Thanks to David Wayne Spurlock for having me out today. Zionsville Football Scott Indiana Preps Zionsville S&C Z'Ville Football Video Steve Wiltfong Bryan Ault - Midwest Scout